Various species of nonhuman primates are natural hosts for 6 exogenous retroviruses, including gibbon-ape leukemia virus (GaLV), simian sarcoma virus, simian T-lymphotropic virus (STLV), simian immunodeficiency virus (SIV), simian type D retrovirus (SRV), and simian foamy virus (SFV). These viruses establish persistent infections with a broad spectrum of pathogenic potential, ranging from highly pathogenic to nonpathogenic, depending on various host, virus, and environmental factors. Latent or subclinical infections are common, and various procedures associated with experimental protocols may lead to virus reactivation and disease. Adverse effects on toxicologic research by undetected retroviral infections can occur in several ways, including loss of experimental subjects (and statistical power) due to increased morbidity and mortality. In addition, results may be confounded by virus-induced clinical abnormalities, histologic lesions, alteration of physiologic parameters and responses, and interference with in vitro assays and/or destruction of primary cell cultures. Key clinical and epidemiological features of several important retroviruses are reviewed, with emphasis on viruses infecting species of macaques most commonly used as research subjects in primate toxicology studies. Examples of actual and potential confounding of toxicologic studies by retroviruses are discussed, including altered cytokine profiles in healthy STLV carriers, and clinical and pathological abnormalities induced by SRV infection. Adequate prestudy viral screening is critical to exclude retrovirus-infected primates from toxicologic research protocols and prevent potential confounding of research results.
Bostik P., Wu P., Dodd GL, Villinger F., Mayne AE, Bostik V., Grimm BD, Robinson D., Kung H-J., Ansari AA (2001). Identification of protein kinases dysregulated in CD4+ T cells in pathogenic and apathogenic simian immuno-deficiency virus infection. J Virol75: 11298—11306.
2.
Carvalho EM, Bacellar O., Porto AF, Braga S., Galvao-Castro B., Neva F. ( 2001). Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors. J Acq Immuno Syndromes27(1): 1—6.
3.
Chopra HC (1970). Electron microscopic detection of an oncogenic-type virus in a monkey breast tumor. Proc Amer AssocCancer Res11: 16.
4.
Colas S., Bourge JF, Wybier J., Chelbi-Alix MK, Paul P., Emanoil-Ravier R. (1995). Human foamy virus infection activates class I major histocompatibility complex antigen expression. J Gen Virol76: 661—667.
5.
Daniel MD, Letvin NL, Sehgal PK, Schmidt DK, Silva DP, Solomon KR, Hodi FS, Ringler DJ, Hunt RD, King NW ( 1988). Prevalence of antibodies to three retroviruses in a captive colony of macaque monkeys. Int J Cancer41: 601—608.
6.
Falcone V., Leupold J., Clotten J., Urbanyi E., Herchenroder O., Spatz W., Volk B., Bohm N., Toniolo A., Neumann-Haefelin D., Schweizer M. (1999). Sites of simian foamy virus persistence in naturally infected African green monkeys: Latent provirus is ubiquitous, whereas viral replication is restricted to the oral mucosa. Virology257: 7—14.
7.
Feldman G., Fickenscher H., Bodemer W., Spring M., Niblein T., Hunsman G., Dittmer U. (1997). Generation of herpesvirus saimiri-transformed T-cell lines from macaques is restricted by reactivation of simian spumaviruses . Virol229(1): 106—112.
8.
Fine DL, Landon JC, Pienta RJ, Kubicek MT, Valerio MG, Loeb WF, Chopra HC (1975). Responses of infant rhesus monkeys to inoculation with Mason-Pfizer monkey virus materials. J Nat Cancer Inst54: 651—658.
9.
Fortmeyer HP (1982). Influence of exogenous factors such as maintenance and nutrition on the course and results of animal experiments. In: Animals in Toxicological Research, Bartosek I, Guaitani A, Pacei E (eds). Raven Press, New York , pp 13—32.
10.
Fultz P. (1994). Simian T-lymphotropic virus type I. In: The Retroviridae vol 3, Levy JA (ed). Plenum Press, New York , pp 111—131.
11.
Gardner MB, Endres M., Barry P. (1994). The simian retroviruses SIV and SRV. In: The Retroviridae vol 3, Levy JA (ed). Plenum Press, New York , pp 133—1276.
12.
Giavedoni LD , Velasquillo MC, Parodi LM, Hubbard GB, Hodara VL (2000). Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J Virol74: 1648—1657.
13.
Guzman RE, Kerlin RL, Zimmerman TE (1999). Histologic lesions in cynomolgus monkeys (Macaca fascicularis) naturally infected with simian retrovirus type D: Comparison of seropositive, virus-positive, and uninfected animals. Toxicol Pathol27(6): 672—677.
14.
Haseman JK, Huff JE, Rao GN, Eustis SL (1989). Sources of variability in rodent carcinogenicity studies. Fundam Appl Toxicol12(4): 793—804.
15.
Heneine W. (1982). Importance of quality standards and quality control in small loaboratory animal animals for toxicological research. In: Anim Toxicol Res, Bartosek I, Guaitani A, Pacei E (eds). Raven Press, New York, pp 1—12.
16.
Johnson PR, Hirsch VM (1992). SIV infection of macaques as a model for AIDS pathogenesis. Int Rev Immunol8: 55—63.
17.
Khan AS, Galvin TA, Lowenstine LJ, Jennings MB, Gardner MB, Buckler CE (1991). A highy divergent simian immunodeficiency virus (SIVstm) recovered from stored stump-tailed macaque tissues. J Virol65: 7061—7065.
18.
Lackner AA, Marx PA, Lerche NW, Gardner MB, Kluge JD, Spinner A., Kwang H-S., Lowenstine LJ (1989). Asymptomatic infection of the central nervous system by the macaque immunosuppressive type D retrovirus SRV1. J Gen Virol70: 1641—1651.
19.
Lackner AA, Moore PF, Marx PA, Munn RJ, Gardner MB, Lowenstine LJ (1990). Immunohistochemical localization of type D retrovirus serotype 1 in the digestive tract of rhesus monkeys with simian AIDS. J Med Primatol19: 339—349.
20.
Lackner AA, Rodriguez MA, Bush CE, Munn RJ, Kwang H-S., Moore , PF, osborn KG,Marx PA,Marx PA, Gardner MB, Lowenstine LJ (1988). Distribution of macaque immuno-suppressive type D retrovirus in neural, lymphoid, and salivary tissues. J Virol62(6): 2134—2142.
21.
Lackner AA, Schiodt M., Armitage GC, Moore PF, Munn RJ, Marx PA, Gardner MB, Lowenstine LJ( 1989). Mucosal epithelial cells and langerhans cells are targets for infection by the immunosuppressive type D retrovirus SRV-1 . J Med Primatol18: 195—207.
22.
Lal RB, Rudolph DL (1991). Constitutive production of interleukin-6 and tumor necrosis factor-alpha from spontaneously proliferating T cells in patients with human T-cell lymphotropic virus type I/II. Blood78: 571—574.
23.
Lazo A., Bailer RT (1996). Constitutive cytokine release by simian T-cell lymphotropic virus type I (STLV-I) and human T-cell lymphotropic virus types I/II (HTLV-I/II) transformed cell lines. J Med Primatol25: 257—266.
24.
Lehky TJ, Cowan EP, Lampson LA, Jacobson S. (1994). Induction of HLA class I and class II expression in human T-lymphotropic virus virus type I-infected neuroblastoma cells. J Virol68: 1854—1863.
25.
Lerche NW, Marx PM, Osborn KG, Maul DH, Lowenstine LJ, Bleviss ML, Moody P., Henrickson RV, Gardner MG (1987). Natural history of endemic type D retrovirus infection and acquired immune deficiency syndrome in grouphoused rhesus monkeys. J Nat Cancer Inst79: 847—854.
26.
Lerche NW, Osborn KG, Marx PM, Prahalada S., Maul DH, Lowenstine LJ, Munn RJ, Bryant ML, Henrickson RV, Arthur LO, Gilden RV, Barker CS, Hunter E., Gardner MB (1986). Inapparent carriers of simian acquired immune deficiency syndrome type D retrovirus and disease transmission with saliva . J Nat Cancer Inst77: 489—495.
27.
Lerche NW, Yee JL, Jennings MB (1994). Establishing specific retrovirus-free breeding colonies of macaques: An approach to primary screening and surveillance. Lab Anim Sci44: 217—221.
28.
Lerche NW (1992). Epidemiology and control of type D retrovirus infection in captive macaques. In: Topics in Primatology, vol 3. Matano S, Tuttle R, Ishida H, Goodman M (eds). University of Tokyo Press , Tokyo, pp 439—447.
29.
Lerche NW, Cotterman R., Dobson MD, Yee JL, Rosenthal AN, Heneine W. (1997). Screening for simian type D retrovirus infection in macaques using nested polymerase chain reaction. Lab Anim Sci47: 263—268.
30.
Lerche NW, Yee JLAltered cytokine profiles in healthy SLTV-1 positive rhesus macaques (Macaca mulatta) Manuscript in preparation.
31.
Lerche NW, Yee JL, Schroder MA (2000) Early detection of antibodies against simian T-lymphotropic virus (STLV) in macaques with commercial HTLV enzyme immunoassays containing recombinant p21e antigen. Manuscript in preparation.
32.
Letvin NL, Daniel MD, Sehgal PK, Sehgal PK, Chalifoux LV, King NW, Hunt RD, Aldrich WR, Holley K., Schmidt DK, Desrosiers RC (1984). Experimental infection of rhesus monkeys with type D retrovirus. J Virol52: 683—686.
33.
Liska V., Fultz PN, Su L., Ruprecht RM (1997). Detection of simian T cell leukemia virus type I infection in seronegative macaques. AIDS Res Hum Retroviruses13: 1147—1153.
34.
Lowenstine LJ , Lerche NW (1988). Retrovirus infections of nonhuman primates: A review. J Zoo Anim Med19(4): 168—187.
35.
Lowenstine LJ , Pedersen NC, Higgins J., Pallis KC, Uyeda A., Marx P., Lerche NW, Gardner MB (1986). Seroepidemiologic survey of captive Old World primates for antibodies to human and simian retroviruses and isolation of a lentivirus from sooty mangabeys (Cercocebus atys). Int J Cancer38: 563—574.
36.
Lowenstine LJ , Lerche NW, Yee JL, Uyeda A., Jennings MB, Munn RJ, McClure HM, Anderson DC, Fultz PN, Gardner MB (1992). Evidence for a lentivirus etiology in an epizootic of immune deficiency and Iymphoma in stump-tailed macaques (Macaca arctoides). J Med Primatol21: 1—14.
37.
MacKenzie M. , Lowenstine L., Lalchandani R., Lerche N., Osborn K., Spinner A., Bleviss M., Henrickson R., Gardner M. (1986). Hematologic abnormalities in simian acquired immune deficiency syndrome. Lab Anim Sci36(1): 59—64.
38.
Marracci GH , Kelley RD, Pilcher KY, Crabtree L., Shiigi SM, Avery N., Leo G., Webb MC, Hallick LM, Axthelm MK, Machida CA (1995). Simian AIDS type D serogroup 2 retrovirus: Isolation of an infectious molecular clone and sequence analysis of its envelope glycoprotein gene and 3' long terminal repeat. J Virol69: 2621—2628.
39.
Marx PA, Lowenstine LJ (1987). Mesenchymal neoplasms associated with type D retroviruses in macaques. Cancer Surv6: 101—114.
40.
Marx PA, Bryant ML, Osborn KG, Maul DH, Lerche NW, Lowenstine LJ, Kluge JD, Zaiss CP, Henrickson RV, Shiigi SM, Wilson BJ, Malley A., Olson LC, McNulty WP, Arthur LO, Gilden RV, Barker CS, Hunter E., Munn RJ, Heidecker G., Gardner MB (1985). Isolation of a new serotype of simian acquired immune deficiency syndrome type D retrovirus from Celebes black macaques (Macaca nigra) with immune deficiency and retroperitoneal fibromatosis. J Virol56: 571—578.
41.
Maul DH, Zaiss CP, MacKenzie MR, Shiigi SM, Marx PA, Gardner MB (1988). Simian retrovirus D serogroup 1 has a broad cellular tropism for lymphoid and nonlymphoid cells. J Virol62(5): 1768—1773.
42.
Meyer PR, Ormerod LD, Osborn KG, Lowenstine LJ, Henrickson RV, Modlin RL, Smith RE, Gardner MB, Taylor CR (1985). An immunopathologic evaluation of lymph nodes from monkey and man with acquired immune deficiency syndrome and related conditions . Hematol Oncol3: 199— 210.
43.
Moazad TC, Thouless ME (1993). Viral persistence of simian type D retrovirus (SRV-2/W) in naturally infected pig-tailed macaques (Macaca nemestrina). J Med Primatol22: 382—389.
44.
Morozov VA, Lagaye S. (1998). Latent foamy and simian retroviruses in healthy African green monkeys used in biomedical research. Lancet351: 1705.
45.
NodaY., IshikawaK., SasagawaA., Honjo S., Mori S., Tsujimoto H., Hayami M. (1986). Hematologic abnormalities similar to the preleukemic state of adult T-cell leukemia in African green monkeys naturally infected with simian T-cell leukemia virus. Jpn J Cancer Res77: 1227—1234.
46.
Noraz N., Verrier B., Fraisier C., Desgranges C. (1995). Cell surface changes incluced in H9 cells chronically infected with HTLV type I or HIV type 1 or coinfected with the two viruses . AIDS Res Hum Retrovir11: 145—154.
47.
Ohta Y., Tsujimoto J., Ishikawa K., Kodama T., Morikawa S., Nakai M., Honjo S., Hayami M. (1988). Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various nonhuman primates. Int J Cancer41: 115—122.
48.
Osborn KG, Prahalada S., Lowenstine LJ, Gardner MB, Maul DH, Henrickson RV (1984). The pathology of an epizootic of acquired immunodeficiency in rhesus macaques. Am J Pathol114: 94—103.
49.
Otsyula M., Yee J., Jennings M., Suleman M., Gettie A., Tarara R., Ishihakia M., Marx P., Lerche N. (1996). Prevalence of antibodies against simian immunodeficiency virus (SIV) and simian T-lymphotropic virus (STLV) in a colony of nonhuman primates in Kenya, East Africa. AnnalsTrop Med Parasitol90: 65—70.
50.
Pakes SP, Lu Y-S., Mevnier PC (1984). Factors that complicate animal research. In: Laboratory Animal Medicine, Fox JG, Cohen BJ, Loew FM (eds.) Academic Press, New York, pp 649—666.
51.
Paramastri YA, Wallace JM, Salleng KJ, Wilkinson LM, Malarkey DE, Cline JM (2000). Intracranial lymphomas in simian retrovirus-positive Macaca fascicularis. Abstract Poster #60, AALAS Annual Meeting, San Diego, California, November 6—9.
52.
Peeters M., Courgnaud V., Abela B., Auzel P., Pourrut X., Bibollett-Ruche F., Loul S., Liegeois F., Butel C., Koulagna D., Mpoudi-Ngole E., Shaw GM, Hahn B., Delaporte E. (2002). Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat. Emerg Inf Dis8: 451—457.
53.
Rose TM, Strand KB, Schultz ER, Schaefer G., Rankin GW, Thouless ME, Tsai CC, Bosch ML (1997). Identification of two homologs of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in retroperitoneal fibromatosis of different macaque species. J Virol71: 4138—4144.
54.
Rosenblum LL , Weiss RA, McClure MO (2000). Virus load and sequence variation in simian retrovirus type 2 infection. J Virol74: 3449— 3454.
55.
Schroder MA , Fisk SK, Lerche NW (2000). Eradication of simian retrovirus type D from a colony of cynomolgus, rhesus, and stump-tailed macaques by using serial testing and removal. Contemp TopicsLab Anim Sci39(4): 16—23.
56.
Shimamoto Y. , Funai N., Watanabe M., Suga K. (1996). Increased production of interferon gamma but not interleukin-4 in human T-lymphotropic virus type 1 carriers. Int J Hematol64: 111—118.
57.
Tsai CC, Follis KE, Snyder K., Windsor S., Thouless ME, Kuller L., Morton WR (1990). Maternal transmission of type D simian retrovirus (SRV-2) in pig-tailed macaques. J Med Primatol19: 203—216.
58.
Tsai CC, Follis KE, Warner TFC (1987). Vertical transmission of simian retroviruses. Lab Invest56: 1A.
59.
Tsai CC, Warner TFC, Uno H., Giddens Jr WE (1985). Subcutaneous fibromatosis associated with an acquired immune deficiency syndrome in pig-tailed macaques. Am J Pathol120: 30—37.
60.
Van der Logt JTM (1993). Microbiological effects and quality control in laboratory rodents. Aging Clin Exp Res5: 317—323.
61.
Villiger PM , Cronin MT, Amenomori T., Wachsman W., Lotz M. (1991). IL-6 production by human T lymphocytes: Expression in HTLV-1-infected but not normal T-cells. J Immunol146: 550—559.
62.
Villinger F. , Folks TM, Lauro S., Powell JD, Sundstrom JB, Mayne A., Ansari AA (1996). Immunological and virological studies of natural SIV infection of disease-resistant nonhuman primates. Immunol Lett51: 59—68.
63.
Yoshioka ST (2000). Effects of simian type D retrovirus serotype 1 on in vitro differentiation of bone marrow derived progenitor cells of the rhesus macaque (Macaca mulatta). Unpublished MS Thesis , University of California, Davis .
64.
Zou W., Lackner AA, Simon M., Durand-Gasselin I., Galanaud P., Desrosiers RC, Emilie D. (1997). Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. J Virol71: 1227—1236.
